Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.
Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.
复制标题
DOI:
10.1007/s00401-017-1679-9
复制
发表时间:
2017-07
影响因子:
12.7
通讯作者:
Trojanowski JQ
中科院分区:
文献类型:
--
作者:
Lee EB;Porta S;Michael Baer G;Xu Y;Suh E;Kwong LK;Elman L;Grossman M;Lee VM;Irwin DJ;Van Deerlin VM;Trojanowski JQ
Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) can typically be categorized into one of four distinct histopathologic patterns of TDP-43 pathology, types A to D. The strength of this histopathologic classification lies in the association between FTLD-TDP subtypes and various clinical and genetic features of disease. Seven cases of FTLD-TDP were identified here which were difficult to classify based on existing pathologic criteria. Distinct features common to these cases included TDP-43 aggregates over a wide neuroanatomic distribution comprised of granulofilamentous neuronal inclusions, abundant grains, and oligodendroglial inclusions. TDP-43 aggregates were phosphorylated and associated with loss of normal nuclear TDP-43 protein (nuclear clearance) but were negative for ubiquitin. Biochemical analysis confirmed the presence of insoluble and phosphorylated TDP-43 and also revealed a distinct pattern of TDP-43 C-terminal fragments relative to other FTLD-TDP subtypes. Finally, these cases were uniformly associated with a very rapid clinical course culminating in death within ~3 years of disease onset. We suggest that these cases may represent a unique clinicopathologic subtype of FTLD-TDP which we provisionally call “type E.” The immature appearance of TDP-43 aggregates, widespread distribution, uniform biochemical profile and rapid clinical course highlights the clinical and pathologic variability within FTLD-TDP, and raises the possibility that type E neuropathology is the sequelae of a particularly virulent strain of TDP-43 proteinopathy.
登录
查看更多内容
影响因子:
16.2
作者:
Giasson, BI;Duda, JE;Lee, VMY
通讯作者:
Lee, VMY
影响因子:
9.9
作者:
Rohrer, J. D.;Guerreiro, R.;Rossor, M. N.
通讯作者:
Rossor, M. N.
影响因子:
--
作者:
Geser, Felix;Martinez-Lage, Maria;Trojanowski, John Q.
通讯作者:
Trojanowski, John Q.
影响因子:
6
作者:
Cairns, Nigel J.;Neumann, Manuela;Mackenzie, Ian R. A.
通讯作者:
Mackenzie, Ian R. A.
影响因子:
7.1
作者:
Kwong, Linda K.;Irwin, David J.;Lee, Virginia M. Y.
通讯作者:
Lee, Virginia M. Y.